selected publications
- Epsilon toxin-producing Clostridium perfringens colonize the MS gut and epsilon toxin overcomes immune privilege. The Journal of clinical investigation. 2023 Academic Article GET IT
- Disease correlates of rim lesions on quantitative susceptibility mapping in multiple sclerosis. Scientific reports. 2022 Academic Article GET IT
- A Multi-Ligand Imaging Study Exploring GABAergic Receptor Expression and Inflammation in Multiple Sclerosis. Molecular imaging and biology. 2020 Academic Article GET IT
-
Impact of Lesion Location on Longitudinal Myelin Water Fraction Change in Chronic Multiple Sclerosis Lesions.
Journal of neuroimaging : official journal of the American Society of Neuroimaging.
2020
Academic Article
GET IT
Times cited: 7 -
Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.
Journal of neurology.
2018
Academic Article
GET IT
Times cited: 1 -
Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.
Multiple sclerosis and related disorders.
2017
Academic Article
GET IT
Times cited: 17 -
Differential Impact of Multiple Sclerosis on Cortical and Deep Gray Matter Structures in African Americans and Caucasian Americans.
Journal of neuroimaging : official journal of the American Society of Neuroimaging.
2016
Academic Article
GET IT
Times cited: 10 -
A study of patients with aggressive multiple sclerosis at disease onset.
Neuropsychiatric disease and treatment.
2016
Academic Article
GET IT
Times cited: 10 -
The pathogenesis and treatment of optic disc swelling in neurosarcoidosis: a unique therapeutic response to infliximab.
2003
GET IT
Times cited: 73